Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Mirum Pharmaceuticals (MIRM) Equity Ratio: 2020-2025

Historic Equity Ratio for Mirum Pharmaceuticals (MIRM) over the last 6 years, with Sep 2025 value amounting to 0.37.

  • Mirum Pharmaceuticals' Equity Ratio rose 7.08% to 0.37 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.37, marking a year-over-year increase of 7.08%. This contributed to the annual value of 0.34 for FY2024, which is 12.53% down from last year.
  • Mirum Pharmaceuticals' Equity Ratio amounted to 0.37 in Q3 2025, which was up 5.81% from 0.35 recorded in Q2 2025.
  • Mirum Pharmaceuticals' Equity Ratio's 5-year high stood at 0.60 during Q1 2021, with a 5-year trough of 0.18 in Q2 2023.
  • Moreover, its 3-year median value for Equity Ratio was 0.35 (2025), whereas its average is 0.35.
  • Its Equity Ratio has fluctuated over the past 5 years, first tumbled by 71.71% in 2021, then soared by 95.56% in 2024.
  • Mirum Pharmaceuticals' Equity Ratio (Quarterly) stood at 0.41 in 2021, then dropped by 1.35% to 0.40 in 2022, then declined by 4.45% to 0.38 in 2023, then decreased by 12.53% to 0.34 in 2024, then rose by 7.08% to 0.37 in 2025.
  • Its Equity Ratio stands at 0.37 for Q3 2025, versus 0.35 for Q2 2025 and 0.34 for Q1 2025.